Peer Review Process
Indonesian Journal of Artificial Intelligence and Multimodal Systems (IJAIMS) applies a rigorous and transparent peer-review process to ensure the quality, integrity, and scientific contribution of all published manuscripts.
All submissions undergo a double-blind peer-review process, where both authors and reviewers remain anonymous throughout the review cycle.
1. Initial Editorial Screening
Upon submission, manuscripts are first evaluated by the Editor-in-Chief or assigned Associate Editor to assess relevance to the journal’s scope, compliance with submission guidelines, and basic methodological soundness. Manuscripts that do not meet these criteria may be desk-rejected.
2. Reviewer Assignment
Eligible manuscripts are assigned to at least two independent reviewers with relevant subject-matter expertise. Reviewers are selected based on academic qualifications, research experience, and the absence of conflicts of interest.
3. Review Criteria
- Originality and novelty of the contribution
- Technical soundness and methodological rigor
- Relevance to artificial intelligence and multimodal systems
- Clarity of presentation and organization
- Validity of results and conclusions
4. Editorial Decision
Based on reviewers’ evaluations and recommendations, the editorial team may reach one of the following decisions:
- Accept without revision
- Minor revision
- Major revision
- Reject
Authors receiving revision requests must submit a revised manuscript along with a detailed response to reviewers’ comments within the specified timeframe.
5. Final Decision
The final publication decision is made by the Editor-in-Chief, considering reviewers’ reports and the revised manuscript. The editorial decision is final.
6. Review Timeline
IJAIMS aims to complete the peer-review process within 4–8 weeks, depending on reviewer availability and manuscript complexity.
7. Ethical Considerations
All participants in the review process are expected to adhere to the journal’s Publication Ethics policy. Reviewers must treat manuscripts as confidential documents and disclose any potential conflicts of interest.